vTv Therapeutics
Price & Volume
Stats
See moreOpen | $32 |
Previous Close | $31.58 |
Day Range | $31.10-$32.35 |
52W Range | $14-$44 |
Market Cap | $131.9M |
Shares Short | 163,681 |
Financials
See moreRevenue (12 Mos) | $36.8M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $12.8M |
Diluted EPS | -$0.78 |
News
See moreYahoo Finance • 12 days ago
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 3 months ago
Small-cap healthcare stocks with A+ grade EPS revisions ahead of earnings
Yahoo Finance • 4 months ago
vTv Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Yahoo Finance • 4 months ago
vTv Therapeutics (VTVT) Secures Global Partnership for PDE4 Inhibitor HPP737
About
CEO | Mr. Paul J. Sekhri |
CFO | Dr. Michael Steven Tung M.B.A., M.D. |
Address | 3980 Premier Drive, High Point, NC, United States, 27265 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 26 |